澳大利亚学校HPV疫苗接种:从两剂到单剂实施的定性研究
澳大利亚2023年2月将学校HPV疫苗从两剂改为单剂,但2023年学校队列单剂覆盖率反而下降。研究者于2024年9月在线访谈11名州/领地高级免疫规划人员,用主题分析记录实施经验与当前挑战,发现沟通延迟、表格追溯修改和疫苗过剩是主要实施困难。
要点
- 单剂次转换因沟通延迟导致同意书追溯修改和疫苗过剩。
- 学校出勤下降、人员配置和数字化同意流程是当前主要挑战。
- 单剂方案可能减少校内接种机会,需加强补种和校外接种宣传。
核心结论
- 单剂HPV疫苗接种实施本身直接,但发生在学校免疫规划面临日益增多挑战的背景下。
- 简化免疫程序可能因仅需一次年度访校而无意中减少校内接种机会。
- 学校接种规划应考虑额外策略支持补种并宣传校外接种选择。
研究设计与样本
- 定性研究,于2024年9月在线访谈11名州和领地高级免疫规划人员。
- 采用主题分析识别类别和主题。
主要发现
- 促进因素包括宣布后清晰一致的沟通、家长和提供者接受以及单剂方案带来的访校时间灵活性增加。
- 主要挑战与时间线短和因政府保密要求延迟沟通 upcoming change 有关,导致挫败感、追溯调整同意书和疫苗供应过剩。
- 当前挑战包括学校出勤下降、人员配置、学校内竞争性优先事项、数字时代同意流程演变以及吸引家长和学生参与免疫接种的难度增加。
临床怎么用
- 学校免疫规划管理者应提前规划沟通策略,避免保密要求导致延迟并影响同意书和疫苗供应。
- 考虑额外策略支持补种接种,并公开宣传学校规划之外的接种选择。
- 关注学校出勤、人员配置和数字化同意流程对接种覆盖的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In Australia, human papillomavirus (HPV) vaccination is routinely offered at age 12-13 years through school-based programs managed by eight states and territories. Coverage has declined since the onset of the COVID-19 pandemic, with widening equity gaps. In February 2023, Australia moved from a two-dose to a single-dose HPV course. While the move was expected to increase coverage, single-dose coverage declined in the school cohort offered vaccination in 2023. We aimed to document the experience of implementing single-dose HPV vaccination and understand the current challenges in school-based immunisation programs. METHODS: In September 2024, we interviewed 11 state and territory senior immunisation staff online about their experiences implementing single-dose HPV vaccination and about current challenges in their programs. We identified categories and themes using thematic analysis. RESULTS: Factors that facilitated the shift to a single dose included clear and consistent communication once the change was announced, acceptance of the change by parents and providers and the increased flexibility in timing for school visits that a single-dose course provides. The main challenge related to the short timeline and a delayed ability to communicate the upcoming change due to government confidentiality requirements. This resulted in frustration, a need to retrospectively adapt consent forms and vaccine oversupply. Current challenges in the school-based immunisation programs include declining school attendance, staffing, competing priorities in schools, evolving consent processes in the digital era and increasing challenges in engaging parents and students in immunisation. CONCLUSIONS: While implementing the change was straightforward, the shift to a single-dose occurred in a setting of increasing challenges to routinely providing immunisation in schools. Simplifying the HPV vaccination schedule may have inadvertently reduced in-school opportunities for vaccination by only requiring one annual visit. School-based vaccination programs should consider additional strategies to support catch-up vaccination and publicise options for vaccination outside of the school program.
引用
- Steffens M, Bolsewicz K, Prokopovich K, et al. Immunisation program managers' experiences of implementing the change from a two dose to a single dose course of HPV vaccination in Australia's school-based program. Vaccine. 2026. PMID: 41653573. doi:10.1016/j.vaccine.2026.128300
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。